Serinus Biosciences Inc.

About

Q&A

What is Serinus Biosciences Inc.'s primary focus?

Serinus Biosciences Inc. is an AI drug discovery company focused on creating combination therapies to overcome cancer treatment resistance.

What technology does Serinus Biosciences Inc. leverage for drug discovery?

Serinus Biosciences Inc. leverages a knowledge-primed AI engine that integrates computational biology and functional genomics to understand the molecular landscape of treatment response and resistance.

When was Serinus Biosciences Inc. founded?

Serinus Biosciences Inc. was founded in 2022.

Where is Serinus Biosciences Inc. headquartered?

Serinus Biosciences Inc. is headquartered in New York, United States.

Who are the founders of Serinus Biosciences Inc.?

The founders of Serinus Biosciences Inc. are Adam Yaari, who serves as Founder/CEO, and Maxwell Sherman.

What are the target markets for Serinus Biosciences Inc.'s technology?

Serinus Biosciences Inc. targets the Cancer Treatment and Drug Discovery markets.

What is Serinus Biosciences Inc.'s primary sector?

Serinus Biosciences Inc.'s primary sector is Biotech.

Team · 2

Adam Yaari

Founder · Founder/CEO

Maxwell Sherman

Founder · Founder

Sectors & technology